NEW YORK (GenomeWeb) – Pacific Biosciences reported today after the close of the market that its fourth quarter 2014 revenues spiked 85 percent year over year.

The Menlo Park, Calif.-based single-molecule sequencing technology firm reported Q4 2014 revenues of $16.9 million, up from $9.1 million in the prior-year period, beating the consensus analyst estimate of $14.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.